Neurosearch Amends the ACR-16 Results
Enviado por SysAdmin el Mar, 06/01/2010.
The press release below involves a correction to previously announced results of the Huntexil (ACR16) clinical trial in Europe.
Dopamine blockers and stabilizers
Compartir soluciones a los desafíos de la enfermedad de Huntington.